Search
Nonacog beta pegol
go.drugbank.com/drugs/DB13933ApprovedInvestigational[A31496] Nonacog beta pegol was developed by Novo Nordisk and received its first global approval by the FDA on May 31, 2017,[L1098] followed by the European Commission approval on June 2, 2017. … [L41185] Nonacog beta pegol was approved by Health Canada on November 29, 2017.[L43682]
Categories: Compounds used in a research, industrial, or household settingSecnidazole
go.drugbank.com/drugs/DB12834ApprovedInvestigational[A245503, A245508] In September 2017, FDA approved secnidazole under the market name Solosec for the treatment of trichomoniasis and bacterial vaginosis.[L39524] … [A27210] Once it enters bacteria and parasites, secnidazole is activated by bacterial or parasitic enzymes to form a radical anion, thereby damaging and killing the target pathogen.
Synonyms: 1-(2-methyl-5-nitro-1H-imidazol-1-yl) propan-2 olMixtures: ITRACONAZOL 33.3 MG + SECNIDAZOL 166.66 MG CÁPSULA, FLUCONAZOL+SECNIDAZOL 75MG/1000 MGCefiderocol
go.drugbank.com/drugs/DB14879ApprovedInvestigational[A189150] A concern noted in the trial was a 0.3% higher rate of all cause mortality, the cause of which has not been determined. … [FDA Label] This indication was supported by a positive clinical trial composed of 448 patients with complicated urinary tract infections which demonstrated a 72.6% rate of symptom resolution and bacterial
Categories: Compounds used in a research, industrial, or household settingDoxercalciferol
go.drugbank.com/drugs/DB06410ApprovedInvestigationalDoxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients … with Stage 3 or Stage 4 chronic kidney disease.
Netilmicin
go.drugbank.com/drugs/DB00955ApprovedThe bactericidal effect of netilmiicin is not fully understood. … Netilmicin is a semisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.
Mixtures: NETİZON 5 MG+15 MG/5 ML GÖZ DAMLASI, ÇÖZELTİ, 1 ADETProducts: NELIN 100 MG / 2ML INJECTION, NELIN 150 MG/ 1.5 ML INJECTIONFenofibric acid
go.drugbank.com/drugs/DB13873ApprovedInvestigational[A32038,L12855] Due to its high hydrophilicity and poor absorption profile,[A32038] prodrug ,[fenofibrate], and other conjugated compounds of fenofibric acid, such as choline fenofibrate, have been developed
Mixtures: FENOVAS®20 MG, FENOVAS®10 MGProducts: TRILIPIX 135 MG, ACIDO FENOFIBRICO 135 MGAntihemophilic factor (recombinant), PEGylated
go.drugbank.com/drugs/DB09329ApprovedInvestigationalPEGylation is the covalent attachment of a polyethylene glycol polymer, called PEG, to a drug or protein. … It has been created to increase the half-life of factor VIII, which decreases dose frequency and decreases the occurrence of bleeding events [A32067], [A32069], [FDA label].
Categories: Compounds used in a research, industrial, or household settingBismuth subcitrate potassium
go.drugbank.com/drugs/DB09275ApprovedInvestigationalA bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease (GORD).
Mixtures: Pylera 140 mg/125 mg/125 mg Hartkapseln, Pylera 140 mg/125 mg/125 mg HartkapselnProducts: KREVAL7.5 MG/5 ML ŞURUP, 200 ML, Ulcamed 120 mg FilmtablettenSulfoxone
go.drugbank.com/drugs/DB01145ApprovedIt has been used with limited success in the treatment of dermatitis herpetiformis.
Categories: Drugs for Treatment of LepraDroloxifene
go.drugbank.com/drugs/DB15641Experimentalgive it theoretical advantages over tamoxifen in the treatment of human breast cancer. … Droloxifene may have an effect on bone and breast tissue because it induces apoptosis.
Categories: Compounds used in a research, industrial, or household setting